HealthIT Answers December 12, 2025

2025 saw major impacts in life science with the rise of generative AI in drug discovery, new global AI regulations, breakthroughs in precision medicine, and accelerated biotech innovation. These shifts reshaped how therapies are discovered, developed, and delivered, while also introducing new risks around compliance, data, and cybersecurity. We asked our experts how will the industry build on this momentum in 2026? Here is what they had to say.

And check out all our prediction posts looking to 2026.

Eden Ben, CEO, Amorphical
LinkedIn: Eden Ben

2026: A Renaissance in Physical Science
The most transformative changes in biopharma often arrive quietly. In 2026, as funding tightens and demand for robust data increases, the focus will shift from spectacle to substance, from how...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article